<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(1)</volume><submitter>Amin AM</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Heart failure (HF) is associated with systemic inflammation and hypercatabolic syndrome, impacting body metabolism. The advanced lung cancer inflammation index (ALI) is a novel inflammatory and nutritional biomarker. We aimed to investigate the prognostic role of ALI in patients with HF.&lt;h4>Methods&lt;/h4>We comprehensively searched PubMed, WOS, SCOPUS, EMBASE, and CENTRAL through October 2024. We conducted a pair-wise and prognostic systematic review and meta-analysis with a reconstructed time-to-event data meta-analysis. All analyses were performed using R V. 4.3.1. This meta-analysis was registered at PROSPERO (CRD42024535227).&lt;h4>Results&lt;/h4>We included five studies with 2,795 patients. In the pair-wise meta-analysis, ALI ≤ 25 was significantly associated with an increa</pubmed_abstract><journal>Cardio-oncology (London, England)</journal><pagination>9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11780879</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Impact of advanced lung cancer inflammation index on all-cause mortality among patients with heart failure: a systematic review and meta-analysis with reconstructed time-to-event data.</pubmed_title><pmcid>PMC11780879</pmcid><pubmed_authors>Elbenawi H</pubmed_authors><pubmed_authors>Ewis A</pubmed_authors><pubmed_authors>Ghaly R</pubmed_authors><pubmed_authors>Elshaer KSM</pubmed_authors><pubmed_authors>Amin AM</pubmed_authors><pubmed_authors>Abuelazm M</pubmed_authors><pubmed_authors>Elgendy IY</pubmed_authors><pubmed_authors>Patel B</pubmed_authors><pubmed_authors>Abdelazeem B</pubmed_authors><pubmed_authors>Timimi FK</pubmed_authors><pubmed_authors>Khan U</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of advanced lung cancer inflammation index on all-cause mortality among patients with heart failure: a systematic review and meta-analysis with reconstructed time-to-event data.</name><description>&lt;h4>Background&lt;/h4>Heart failure (HF) is associated with systemic inflammation and hypercatabolic syndrome, impacting body metabolism. The advanced lung cancer inflammation index (ALI) is a novel inflammatory and nutritional biomarker. We aimed to investigate the prognostic role of ALI in patients with HF.&lt;h4>Methods&lt;/h4>We comprehensively searched PubMed, WOS, SCOPUS, EMBASE, and CENTRAL through October 2024. We conducted a pair-wise and prognostic systematic review and meta-analysis with a reconstructed time-to-event data meta-analysis. All analyses were performed using R V. 4.3.1. This meta-analysis was registered at PROSPERO (CRD42024535227).&lt;h4>Results&lt;/h4>We included five studies with 2,795 patients. In the pair-wise meta-analysis, ALI ≤ 25 was significantly associated with an increa</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2025-04-04T22:24:35.256Z</modification><creation>2025-04-04T22:24:35.256Z</creation></dates><accession>S-EPMC11780879</accession><cross_references><pubmed>39885521</pubmed><doi>10.1186/s40959-024-00295-1</doi></cross_references></HashMap>